Our study demonstrated that OBS administration effectively mitigated CIS-induced inflammation, oxidative stress, and cell death in the kidney and liver tissues of mice, primarily through the activation of the Nrf2/HO-1 pathway. This evidence concerns the gene NFE2L2 and in situ carcinoma.